Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap4.18K
Market cap4.18K
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume17.42K
Average volume17.42K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume9.69K
Volume9.69K
52 Week high$1.27
52 Week high$1.27
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 4.18K, Carisma Therapeutics(CARM) trades at $0.00. The stock has a price-to-earnings ratio of 0.00.
During the trading session on 2026-05-26, Carisma Therapeutics(CARM) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 9.69K, compared to an average daily volume of 17.42K.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $1.27 and a low of $0.00.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $1.27 and a low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.